Actavis Reports Underlying Profits of EUR 29 Million in 3Q
09. November 2006 13:47 ET
|
Actavis
REYKJAVIK, Iceland, Nov. 9, 2006 (PRIMEZONE) -- Actavis Group ("ACT"), the international generic pharmaceuticals company, announces its results for the third quarter ended 30 September,...
Actavis Launches Glipizide ER Tablets in the U.S.
06. November 2006 08:27 ET
|
Actavis
CRANFORD, N.J. and REYKJAVIK, Iceland, Nov. 6, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, today announced that Actavis U.S., its manufacturing and...
Actavis Divests Its Stake in PLIVA
20. Oktober 2006 12:11 ET
|
Actavis
REYKJAVIK, Iceland, Oct. 20, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, announces that a total of 20.8% of PLIVA's share capital that Actavis...
Actavis Responds to Barr Pharmaceuticals' Increased Offer For PLIVA
18. September 2006 06:42 ET
|
Actavis
REYKJAVIK, Iceland, Sept. 18, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, has noted the increased offer published on September 11th, to acquire...
Actavis Announces FDA Warning Letter Following FDA Inspection
14. September 2006 07:49 ET
|
Actavis
REYKJAVIK, Iceland, Sept. 14, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, announced today that it has received a warning letter from the U.S. Food...
Actavis Raises Offer for PLIVA to HRK 795
31. August 2006 09:52 ET
|
Actavis
REYKJAVIK, Iceland, Aug. 31, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceutical company, today announces that it has increased its offer to acquire the Croatian...
Actavis Group Updated Financial Guidance for Full Year 2007
11. August 2006 08:43 ET
|
Actavis
REYKJAVIK, Iceland, Aug. 11, 2006 (PRIMEZONE) -- Actavis Group hf. (ICEX:ACT), the international generic pharmaceuticals company, announces following its earnings release this morning, that the...
Actavis Trebles Net Profits to EUR30 Million for 2Q 2006
10. August 2006 15:14 ET
|
Actavis
REYKJAVIK, Aug. 10, 2006 (PRIMEZONE) -- Actavis Group ("ACT") (ICEX:ACT), the international generic pharmaceuticals company, announces its results for the second quarter ended 30 June 2006. Sindan,...
Actavis Submits a Request for Approval to Publish a Takeover Bid of PLIVA
10. August 2006 11:36 ET
|
Actavis
REYKJAVIK, Iceland, Aug. 10, 2006 (PRIMEZONE) -- Actavis Group hf. (ICEX:ACT), the international generic pharmaceuticals company, announces that it has submitted, on 9 August 2006, a request for the...
Actavis Launches Meloxicam Tablets in the U.S.
03. August 2006 06:49 ET
|
Actavis
REYKJAVIK, Iceland, Aug. 3, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food &...